Scheduled for Second Half of January -PURCHASE, N.Y., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing ...

UCLA Anderson Executive Education announces the launch of the Board Director Program, a four-month learning journey designed to prepare experienced executives and emerging board leaders for effective ...

A clear breakdown of how the UK Autumn Budget's tax changes—from frozen thresholds to new caps and allowances—will reshape ...

By aligning IPO targets with IMF requirements, Egypt seeks to unlock foreign investments and reinforce its credibility in ...

Warba Bank’s “Rowad” program, now in its sixth edition, continues its successful journey in nurturing and developing young ...

Five outstanding Jamaicans have been awarded Fulbright Scholarships to pursue advanced studies in the United States (US).

VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the U.S.

Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, ...

Biotech veteran with over 25 years of business development, strategy and operational experience joins March Bio’s management team ...

Get complete information on the Inlaks Shivdasani Foundation Scholarships, including eligibility criteria, application and ...

The rise of AI in society overall is seeping into the senior living industry, as companies and communities adopt various programs and processes to improve efficiencies and resident satisfaction.

CKM syndrome, which links heart disease, kidney disease, diabetes, and obesity, is a fairly new concept. As a result, ...